Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and GenderCraft S.a,c · Asthana S.a,d · Schellenberg G.a,e,f · Cherrier M.a,c · Baker L.D.a,c · Newcomer J.g · Plymate S.a,d · Latendresse S.a · Petrova A.a · Raskind M.b,c · Peskind E.b,c · Lofgreen C.a · Grimwood K.a,c
aGeriatric Research, Education, and Clinical Center, and bMental Health Service, Veteran Affairs Puget Sound Health Care System, and Departments of cPsychiatry and Behavioral Sciences, dMedicine, ePharmacology, and fNeurology, University of Washington School of Medicine, Seattle, Wash., and gDepartment of Psychiatry, Washington University, St. Louis, Mo., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Higher fasting plasma insulin levels and reduced CSF-to-plasma insulin ratios, suggestive of insulin resistance, have been observed in patients with Alzheimer’s disease (AD) who do not possess an apolipoprotein E (APOE)-Ε4 allele. We examined the relationship of APOE and gender to peripheral insulin action and hyperinsulinemic memory facilitation in patients with AD using a sensitive measure of insulin-mediated glucose disposal. Participants were 32 patients with AD (9 without an Ε4 allele, 23 with an Ε4 allele) and 25 healthy age-matched adults (16 without an Ε4 allele, 9 with an Ε4 allele). AD subjects without an Ε4 allele had significantly lower insulin-mediated glucose disposal rates than AD patients with an Ε4 allele (p < 0.03), or than normal adults without an Ε4 allele (p < 0.02). Female AD subjects showed lower insulin-mediated glucose disposal rates than did male AD subjects (p < 0.02). No significant interaction was observed between APOE group and gender, suggesting that these effects are independent. AD subjects without an Ε4 allele also showed significant memory facilitation in the hyperinsulinemic condition (p < 0.04), whereas the AD-Ε4 group did not. Also in the hyperinsulinemic condition, AD patients without an Ε4 allele had lower insulin levels than patients with an Ε4 allele (p < 0.02), and women with AD had lower insulin levels than did men with AD despite similar insulin infusion rates and body mass (p < 0.004). No gender or genotype effects were observed in either condition for normal subjects. These results provide in vivo evidence of differences in insulin-mediated energy metabolism between Ε4 and non-Ε4 AD, and suggest that defective insulin action may be of particular pathophysiologic significance for patients without an Ε-4 allele.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.